Emukah E., Gutman J., Eguagie J., Miri E.S., Yinkore P., Okocha N., Jibunor V., Nebe O., Nwoye A.I., Richards F.O.
The Carter Center, Plot R/60 GRA, Off High Court Road, Box 4034, Owerri, Imo State, Nigeria; Emory University and Children's Healthcare of Atlanta at Egleston, 2015 Uppergate Dr., Atlanta, GA 30322, United States; The Carter Center, 1 Jeka Kadima Street,
Emukah, E., The Carter Center, Plot R/60 GRA, Off High Court Road, Box 4034, Owerri, Imo State, Nigeria; Gutman, J., Emory University and Children's Healthcare of Atlanta at Egleston, 2015 Uppergate Dr., Atlanta, GA 30322, United States; Eguagie, J., The Carter Center, 1 Jeka Kadima Street, Box 7772, Jos, Nigeria; Miri, E.S., The Carter Center, 1 Jeka Kadima Street, Box 7772, Jos, Nigeria; Yinkore, P., Primary Health Care Development Agency, Ministry of Health, No. 1 Onyeka Close, Off Delta Broadcasting Service Road, Near LGSC, Asaba, Delta State, Nigeria; Okocha, N., Primary Health Care Development Agency, Ministry of Health, No. 1 Onyeka Close, Off Delta Broadcasting Service Road, Near LGSC, Asaba, Delta State, Nigeria; Jibunor, V., Primary Health Care Development Agency, Ministry of Health, No. 1 Onyeka Close, Off Delta Broadcasting Service Road, Near LGSC, Asaba, Delta State, Nigeria; Nebe, O., Federal Ministry of Health, Federal Secretariat Phase 3, Garki Abuja, Nigeria; Nwoye, A.I., Federal Ministry of Health, Federal Secretariat Phase 3, Garki Abuja, Nigeria; Richards, F.O., The Carter Center, One Copenhill Avenue NE, Atlanta, GA 30307-1406, United States
Nigeria is highly endemic for infection with Schistosoma haematobium, which most commonly manifests itself with blood in urine. To monitor the impact of annual mass drug administration (MDA) with Praziquantel for S. haematobium in Delta State, Nigeria, cross-sectional hematuria surveys of school children were conducted in 8 sentinel villages (SVs) at baseline (n= 240) and after two annual doses (n= 402). We assessed the comparability of three assessments of hematuria (child's reported history, nurse visual diagnosis (NVD) and dipstick) to determine the need for mass treatment. Dipstick was considered to be the gold standard. Prior to treatment, history and NVD each identified only the 3 most highly prevalent SVs, and overall this represented just 37.5% of the 8 SVs in need of treatment. Following treatment, after dipstick prevalence decreased by 88.5% (p< 0.001), and history and NVD identified only one of two villages still needing treatment. The study suggests that dipsticks should be the recommended method for launching and monitoring mass treatment for S. haematobium. © 2012.